• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    NurExone Secures EMA Orphan Status for ExoPTEN in Spinal Injury

    GLOBENEWSWIRE

    Nurexone Initiates European Orphan Drug Designation Process Following U.S. Grant

    GLOBENEWSWIRE

    NurExone Biologic Receives FDA Orphan-Drug Designation of ExoPTEN therapy

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.